Offer - Urjas Oil for just ₹ 1 X
Diaglip M is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Diaglip M have also been explained below.
The optimal dosage of Diaglip M is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Diaglip M are Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Diaglip M can also lead to other problems, which have been listed below. Such side effects of Diaglip M normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Diaglip M is Mild for pregnant women and Moderate for women who are breastfeeding. Warnings related to Diaglip M's effects on the liver, heart and kidney, if any, have been listed below.
Diaglip M is contraindicated in people with pre-existing medical conditions like Liver Disease, Heart Disease, Kidney Disease as it can result in adverse effects. Other contraindications of Diaglip M have been discussed in the sections ahead.
Drug interactions for Diaglip M have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Diaglip M is considered safe while driving, and is addictive.
Diaglip M is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Diaglip M safe for pregnant women?
Diaglip M rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Diaglip M safe during breastfeeding?
Diaglip M can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Diaglip M on the Kidneys?
There are no side effects of Diaglip M on the kidneys.
What is the effect of Diaglip M on the Liver?
Diaglip M does not damage the liver.
What is the effect of Diaglip M on the Heart?
Using Diaglip M does not have any harmful effects on the heart.
Diaglip M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diaglip M unless your doctor advises you to do so -
Is this Diaglip M habit forming or addictive?
Diaglip M does not cause addiction.
Interaction between Food and Diaglip M
There is no information on the effects of taking Diaglip M with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Diaglip M
Taking alcohol with Diaglip M can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826